Bone disease after jejuno-ileal bypass for obesity

Area of Science:

• Gastroenterology
• Endocrinology
• Orthopedics

Background:

• Jejuno-ileal bypass surgery was a treatment for obesity.
• Bone disease, specifically osteomalacia, can be a complication.
• Secondary hyperparathyroidism may accompany osteomalacia.

Purpose of the Study:

• To investigate bone tissue in patients post-jejuno-ileal bypass.
• To assess the prevalence and characteristics of osteomalacia.
• To identify factors contributing to bone disease.

Main Methods:

• Examination of bone tissue from 21 patients who had undergone jejuno-ileal bypass.
• Clinical, biochemical, and radiological assessments.
• Measurement of plasma-25-hydroxyvitamin-D, plasma-phosphate, and plasma-parathyroid-hormone.

Main Results:

• 10 out of 21 patients had osteomalacia with secondary hyperparathyroidism.
• Diagnostic methods like clinical symptoms and radiological findings were often unreliable.
• Lower plasma-25-hydroxyvitamin-D and plasma-phosphate, and higher plasma-parathyroid-hormone were observed in patients with bone disease.
• Osteomalacia prevalence was not linked to age, time since bypass, or weight loss.
• Plasma-25-hydroxyvitamin-D levels did not strongly correlate with histological bone changes.

Conclusions:

• Osteomalacia is a frequent complication following jejuno-ileal bypass surgery.
• Diagnosis of bone disease can be difficult using standard methods.
• Factors beyond simple vitamin D deficiency likely contribute to the development of osteomalacia post-bypass.